OBJECTIVE: This study aims to evaluate the associations of @entity1109 ( @entity1109 ) frequency, bother, and severity with @entity20788 producer status and dietary @entity8139 intake. METHODS: This is an observational study. This study included @entity1 aged 45 to 55 years, in postmenopause or in the menopausal transition, who had soy food intake of three or more servings per week. Exclusion criteria included severe concurrent disease, pregnancy or planned pregnancy, and current use of oral or transdermal hormones or selective @entity172 receptor modulators. After screening, 375 @entity1 completed a 3-day @entity1109 diary and a 24-hour urine collection. @entity1 with a urine @entity8139 or @entity670 concentration of 100 ng/mL or higher were included. We evaluated the association of @entity1109 -dichotomized as lower than or equal to versus higher than the mean number of @entity1109 per day (<2.33, >= 2.33)-with quartiles of @entity8139 intake. RESULTS: Overall, 129 (35%) of 365 @entity1 were @entity20788 producers. The mean (SD) urinary @entity20788 excretion was 0.67 (1.57) mg/day (50th percentile, 0 mg/d; 95th percentile, 4.12 mg/d). Among @entity20788 producers, the mean (SD) urinary @entity20788 excretion was 1.91 (2.15) mg/day (50th percentile, 1.09 mg/d; 95th percentile, 6.27 mg/d). Among @entity20788 producers, compared with those in the lowest quartile of dietary @entity8139 intake (mean, 4.9 mg/d), those in the highest quartile (mean, 28.5 mg/d) were 76% less likely to have @entity1109 higher than the mean number of @entity1109 (odds ratio, 0.24; 95% CI, 0.07-0.83; trend test across all @entity8139 levels, P = 0.06). Among @entity20788 nonproducers, there were no associations between @entity8139 intake and @entity1109 frequency. There were no differences in @entity1109 bother or severity among @entity20788 producers or nonproducers by dietary @entity8139 level. CONCLUSIONS: Among @entity20788 producers, higher @entity20788 availability attributable to higher soy consumption contributes to decreased @entity1109 .

A cross-sectional study of XXXX producer status and self-reported vasomotor symptoms.

@entity1 :: ('9606', 'Species') :: ['participants', 'women', 'Women'] @entity8139 :: ('MESH:C004742', 'Chemical') :: ['daidzein'] @entity172 :: ('MESH:D004967', 'Chemical') :: ['estrogen'] @entity670 :: ('MESH:D019833', 'Chemical') :: ['genistein'] @entity1109 :: ('MESH:D012678', 'Disease') :: ['VMS', 'vasomotor symptom'] @entity20788 :: ('MESH:D060754', 'Chemical') :: ['equol']
@entity20788 :: (MESH:D060754,Chemical) :: ['equol']
